Self Expanding Covered Stents Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Self-expanding covered stents are a class of vascular medical devices combining the radial support of a metallic or polymeric scaffold with an external covering that restrains neointimal hyperplasia. The segment sits within a global stents market estimated between $10.1 billion and $15.44 billion in 2026, with the covered stent sub-segment specifically valued at approximately $1.4 to $1.5 billion in 2025-2026. The broader self-expanding stent category alone is projected between $3.77 billion and $5.2 billion by 2031 depending on report scope.

• •Global stents market reported between $10.1B and $15.44B in 2025-2026 across various industry sources
• •Covered stent sub-segment estimated at $1.4B-$1.5B in 2025-2026 with incremental annual growth
• •Self-expanding stent segment projected at $3.77B to $5.2B by 2031 with CAGRs of 4.53% to 5%+

The primary engine of market growth is the rising global burden of peripheral arterial disease and coronary artery disease, driven by sedentary lifestyles, diabetes prevalence, and population aging. Advances in stent materials, including nitinol alloys and bioabsorbable polymers, have expanded the indications for self-expanding covered stents, particularly in long-segment occlusions and bifurcation lesions. Reimbursement support in major healthcare systems and the shift toward minimally invasive endovascular procedures over open surgical repair further sustain demand.

• •Rising prevalence of cardiovascular and peripheral artery diseases tied to aging populations and metabolic conditions
• •Clinical advantages of covered designs in reducing restenosis and addressing complex lesion anatomies
• •Preference for minimally invasive endovascular interventions over surgical approaches driving procedural volume

The market is broadly segmented by product type, metal stents (predominantly nitinol-based self-expanding platforms), polymer stents, and covered variants incorporating ePTFE or woven fabric liners. Application segments include coronary, peripheral vascular (iliac, femoral, popliteal), and non-coronary uses such as tracheobronchial and esophageal stenting. North America and Europe constitute the largest regional markets, supported by advanced healthcare infrastructure and high procedural adoption, while Asia-Pacific is the fastest-growing region due to expanding access and rising disease burden.

• •Major segments: metal stents (nitinol self-expanding), polymer stents, and covered/bifurcation stents
• •Applications span coronary, peripheral vascular (iliac, femoral, carotid), and non-coronary (tracheobronchial, esophageal) indications
• •North America and Europe hold the largest share; Asia-Pacific is the fastest-expanding region

Who are the notable companies in the industry?

**Competitive Landscape** The global self-expanding covered stent market is anchored by a concentrated group of established vascular and interventional device manufacturers whose portfolios span iliac, peripheral, and biliary indications. **Abbott** fields two nitinol platforms, the Absolute Pro Vascular Stent and the Supera Peripheral Stent System, addressing iliac and peripheral lesions. **Teleflex** competes through its Astron nitinol stent, indicated for improving luminal diameter in iliac atherosclerotic lesions within vessel reference diameters of 4.3-9.5 mm. **Veryan Medical** differentiates with the BioMimics 3D Vascular Stent System, a nitinol design tailored to the superficial femoral artery and proximal popliteal. **BD Interventional** maintains one of the broadest footprints in the dataset, offering the E-Luminexx Biliary Stent alongside E-Luminexx, LifeStar, and LifeStent 5F vascular platforms that collectively cover biliary, iliac, and lower-extremity indications. **Boston Scientific Corporation** contributes the Epic Vascular Self-Expanding Stent System for iliac use and the Innova platform, a bare-metal nitinol system explicitly designed for the SFA and proximal popliteal arteries. **Medtronic** rounds out the field with its EverFlex Self-Expanding Peripheral Stent System (including an Entrust delivery variant), offered across iliac, SFA, and proximal popliteal configurations.

• •Market structure ranges from moderately to highly concentrated, with large integrated medtech firms dominating through regulatory breadth and R&D scale
• •Feedstock and process routes center on nitinol shape-memory alloy tubing, laser-cut scaffold design, and polymer/ePTFE covering lamination
• •Manufacturing capacity is geographically concentrated in North America, Western Europe, and increasingly in East Asia, reflecting both regulatory headquarter locations and cost-competitive fabrication hubs

What are the recent trends and outlook?

Key trends shaping the market include the development of bioabsorbable and drug-eluting covered stents aimed at reducing long-term implant complications, as well as the adoption of robotics-assisted delivery systems for improved precision in tortuous anatomies. Regulatory harmonization efforts and real-world evidence generation are accelerating product lifecycle management. The market is expected to sustain its 5.3% annual growth trajectory, with value reaching well beyond $13.447 billion as emerging market adoption matures and next-generation platforms gain clinical validation.

• •Next-generation platforms incorporating bioabsorbable materials and drug-eluting technologies are in active clinical development
• •Robotic and computer-assisted delivery systems are gaining clinical traction for complex anatomical access
• •Continued market consolidation through M&A and organic portfolio expansion is expected as firms seek to broaden vascular product breadth